How do you approach a denial for DOTATATE PET in a 1.5 cm G3 gastric body NET with favorable histology when MRI/CTAP is recommended first, and how do high-risk features influence your use of EUS as an alternative, supplemental, or complementary modality?
How do you approach a denial for DOTATATE PET in a 1.5 cm G3 gastric body NET with favorable histology when MRI/CTAP is recommended first, and how do high-risk features influence your use of EUS as an alternative, supplemental, or complementary modality? | Mednet
